Medicure Inc. (TSXV: MPH) (OTC: MCUJF), a Canada-based company focused on the development and commercialisation of pharmaceuticals and healthcare products for patients and prescribers in the United States market, announced on Thursday its financial results for the quarter ended 30 September 2022.

The firm posted net income for the quarter at CAD1.1m or CAD0.11 per share, against a net loss of CAD946,000 or CAD0.09 per share for the same period in 2021.

The company reported total net revenue of CAD5.3m during the quarter ended 30 September 2022 compared to CAD4.9m in the year-ago period.

(USD1=CAD1.33)